Probiotics and prebiotics in pediatrics: Where are we now?

Turkish Journal of Pediatrics

Volumn 49, Issue 3, 2007, Pages 231-244

  Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute gastroenteritis; Acute infectious diarrhea; Allergy; Antibiotic associated diarrhea; Atopic dermatitis; Atopic disease; Children; Necrotizing enterocolitis; Nosocomial diarrhea; Prebiotics; Probiotics

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CARBOHYDRATE; CELLULOSE; FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GUM ARABIC; INULIN; LACTOSE; MALTODEXTRIN; OLIGOFRUCTOSE; OLIGOSACCHARIDE; PLACEBO; POLYSACCHARIDE; POTATO STARCH; PREBIOTIC AGENT; PROBIOTIC AGENT; ROTAVIRUS VACCINE; STARCH; UNCLASSIFIED DRUG; ZINC;

ACUTE DIARRHEA; ARTIFICIAL MILK; ATOPIC DERMATITIS; ATOPY; BIFIDOBACTERIUM LONGUM INFANTIS; CEREAL; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG MECHANISM; ECZEMA; GASTROENTERITIS; HUMAN; INFECTION CONTROL; INFECTIOUS DIARRHEA; LACTOBACILLUS ACIDOPHILUS; META ANALYSIS; MONOTHERAPY; NECROTIZING ENTEROCOLITIS; NONHUMAN; ORAL REHYDRATION THERAPY; PEDIATRICS; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; STREPTOCOCCUS THERMOPHILUS; SYSTEMATIC REVIEW; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT, NEWBORN; META-ANALYSIS AS TOPIC; PEDIATRICS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 35248819761     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. FAO/WHO, Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria. Cordoba. Argentina, 2001.
2. Bernardeau M, Vernoux JP, Gueguen M. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. Int J Food Microbiol 2002; 77: 19-27.
3. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002; 122: 1428-1441.
4. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004; 126: 1358-1373.
5. Dunne C, O'Mahony L, Murphy E, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001; 73(Suppl): S386-S392.
6. Guarner F, Perdigon G, Corthier G, Salminen S, Koletzko B, Morelli L. Should yoghurt cultures be considered probiotic? Br J Nutr 2005; 93: 783-786.
7. Goldin BR, Gorbach SL, Saxelin M, et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37: 121-128.
8. Silva M, Jacobus NV, Deneke C, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-1233.
9. Coconnier MH, Lievin V, Bernet-Camard MF, et al. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41: 1046-1052.
10. Wilson KH, Perini I. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immunol 1988; 56: 2610-2614.
11. Walker WA. Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr 2000; 30: S2-S7.
12. Bernet MF, Brassart D, Nesser JR, et al. Lactobacillus acidophilus LA1 binds to human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35: 483-489.
13. Davidson JN, Hirsch DC. Bacterial competition as a mean of preventing diarrhea in pigs. Infect Immun 1976; 13: 1773-1774.
14. Rigothier MC, Maccanio J, Gayral P. Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res 1994; 80: 10-15.
15. Michail S, Abernathy F. Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutt 2002; 35: 350-355.
16. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108-1115.
17. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3′,5′-cyclic monophosphate induction in intestinal cells. Gastroenterology 1994; 106: 65-72.
18. De Simone C, Ciardi A, Grassi A, et al. Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992; 14: 331-340.
19. Aattour N, Bouras M, Tome D, et al. Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-gamma production. Br J Nutr 2002; 87: 367-373.
20. Isolauri E, Joensuu J, Suomalainen H, et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13: 310-312.
21. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-144.
22. Majamaa H, Isolauri E, Saxelin M, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 333-338.
23. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64: 5403-5405.
24. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-G950.
25. Isolauri E, Majamaa H, Arvola T, et al. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105: 1643-1650.
26. Lievin-Le Moal V, Amsellem R, Servin AL, Coconnier M-H. Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrheagenic Escherichia coli in human enterocyte-like cells. Gut 2002; 50: 803-811.
27. Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr 2001; 33: S17-S25.
28. Van Niel C, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 678-684.
29. Huang JS, Bousvaros A, Lee JW, et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47: 2625-2634.
30. Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. The Cochrane Database of Systematic Reviews 2003, Issue 4.
31. Szajewska H, Skórka A, Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 257-264.
32. Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 871-881.
33. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br Med J 2002; 324: 1361-1364.
34. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461-1467.
35. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment Pharmacol Ther 2005; 22: 365-372.
36. Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 2005; 72: 51-56.
37. Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149: 367-372.
38. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 2006; 175: 377-383. Erratum in: CMAJ. 2006; 175: 777.
39. Dendukuri N, Costa V, McGregor M, Brophy J. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005; 173: 167-170.
40. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-822.
41. Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis 1990; 162: 598-604.
42. Ford-Jones EL, Mindorff CM, Gold R, et al. The incidence of viral-associated diarrhea after admission to a pediatric hospital. Am J Epidemiol 1990; 131: 711-718.
43. Ponce MF, Rial MJ, Alarcon N, et al. Use of a prospectively measured incidence rate of nosocomial diarrhea in an infant/toddler ward as a meaningful quality assessment tool. Clin Perform Qual Health Care 1995; 3: 128-131.
44. Szajewska H, Kotowska M, Mrukowicz J, Armanska M, Mikolajczyk W. Lactobacillus GG in prevention of diarrhea in hospitalized children. J Pediatr 2001; 138: 361-365.
45. Mastretta E, Longo P, Laccisaglia. A, Balbo L, Russo R. Lactobacillus GG and breast feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastr Nutr 2002; 35: 527-531.
46. Saavedra J, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994; 344: 1046-1049.
47. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 2004; 38: 288-292.
48. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82: 103-108.
49. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
50. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-196.
51. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107: 129-134.
52. Kalliomaki M, Salminen S. Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 357: 1076-1079.
53. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-1871.
54. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.
55. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119: 184-191.
56. Abrahamsson TR, Jakobsson T, Boucher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; [Epub ahead of print].
57. ESPGHAN Committee on Nutrition. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004; 38: 365-374.
58. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118.
59. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-1412.
60. Eshach Adiv O, Berant M, Shamir R. New supplements to infant formulas. Pediatr Endocrinol Rev 2004; 2: 216-224.
61. Dai D, Walker WA. Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 1999; 46: 353-382.
62. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130: S78-S90.
63. Veerman-Wauters G. Application of prebiotics in infant foods. Br J Nutr 2005; 93: S57-S60.
64. Forchielli ML, Walker WA. The role of gut-associated lymphoid tissue and mucosal defence. Br J Nutt 2005; 93: S41-S48.
65. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, et al. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha. J Nutr Biochem 2004; 15: 220-228.
66. Watzl B, Girrbach S, Roller M. Inulin, oligofructose and immunomodulation. Br J Nutr 2005; 93: S49-S55.
67. Coudray C, Tressol JC, Gueux E, Rayssiguier Y. Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption of calcium and magnesium in rats. Eur J Nutr 2003; 42: 91-98.
68. Roberfroid MB, Cumps J. Devogelaer JP. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 2002; 132: 3599-3602.
69. ESPGHAN Committee on Nutrition: Agostoni C, Axelsson I, Goulet O, et al. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004; 39: 465-473.
70. Moore N, Chao C, Yang LP, et al. Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. Br J Nutr 2003; 90: 581-587.
71. Scholtens PA, Alles MS, Bindels JG, et al. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 2006; 42: 553-559.
72. Vesikari T, Matson DO, Dennehy P. et al., and Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 23-33.
73. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al., and Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22.
74. Duggan C, Penny ME, Hibberd P, et al. Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants. Am J Clin Nutr 2003; 77: 937-942.
75. Hoekstra JH, Szajewska H, Zikri MA, et al. Oral rehydration solution containing a mixture of non-digestible carbohydrates in the treatment of acute diarrhea: a multicenter randomized placebo controlled study on behalf of the ESPGHAN working group on intestinal infections. J Pediatr Gastroenterol Nutr 2004; 39: 239-245.
76. Brunser O, Gotteland M, Cruchet S, et al. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment. Pediatr Res 2006; 59: 451-456.
77. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006; 61: 431-437.
78. Moro G, Arslanoglu S, Stahl B, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006; 9: 814-819.
79. Griffin IJ, Davila PM, Abrams SA. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 2002; 87: S187-S191.
80. Van den Heuvel EG, Muys T, van Dokkum W, et al. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 1999; 69: 544-548.
81. Abrams SA, Griffin IJ, Hawthorne KM, et al. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 2005; 82: 471-476.